Opioid peptides affect different immune functions. We present evidence that these effects could be mediated by the modulation of T(H)1/T(H)2 cytokine production. BALB/cJ mice were immunized with 50 or 100 μg of the protein antigen keyhole-limpet hemocyanin (KLH), and treated acutely or chronically with the opioid antagonist naloxone. One and 2 weeks after immunization, the production of cytokines by splenocytes was evaluated by in vitro restimulation with KLH. The acute and chronic treatment with the opioid receptor antagonist naloxone decreased the production of interleukin (IL)-4 by splenocytes of BALB/cJ mice. In contrast, IL-2 and interferon-γ levels increased after naloxone treatment. Finally, the opioid antagonist diminished the serum immunoglobulin G anti-KLH antibody titers. These results suggest that naloxone increases T(H)1 and decreases T(H)2 cytokine production. The effect of naloxone could be ascribed to the removal of the regulatory effects exerted by endogenous opioid peptides, which could therefore activate T(H)2 and suppress T(H)1 cytokines. (C) 2000 by The American Society of Hematology.

The opioid antagonist naloxone induces a shift from type 1 cytokine pattern to type 2 cytokine pattern in balbc/Jmice / P. Sacerdote, B. Manfredi, L. Gaspani, A.E. Panerai. - In: BLOOD. - ISSN 0006-4971. - 95:6(2000), pp. 2031-2036.

The opioid antagonist naloxone induces a shift from type 1 cytokine pattern to type 2 cytokine pattern in balbc/Jmice

P. Sacerdote
Primo
;
B. Manfredi
Secondo
;
A.E. Panerai
Ultimo
2000

Abstract

Opioid peptides affect different immune functions. We present evidence that these effects could be mediated by the modulation of T(H)1/T(H)2 cytokine production. BALB/cJ mice were immunized with 50 or 100 μg of the protein antigen keyhole-limpet hemocyanin (KLH), and treated acutely or chronically with the opioid antagonist naloxone. One and 2 weeks after immunization, the production of cytokines by splenocytes was evaluated by in vitro restimulation with KLH. The acute and chronic treatment with the opioid receptor antagonist naloxone decreased the production of interleukin (IL)-4 by splenocytes of BALB/cJ mice. In contrast, IL-2 and interferon-γ levels increased after naloxone treatment. Finally, the opioid antagonist diminished the serum immunoglobulin G anti-KLH antibody titers. These results suggest that naloxone increases T(H)1 and decreases T(H)2 cytokine production. The effect of naloxone could be ascribed to the removal of the regulatory effects exerted by endogenous opioid peptides, which could therefore activate T(H)2 and suppress T(H)1 cytokines. (C) 2000 by The American Society of Hematology.
Settore BIO/14 - Farmacologia
http://bloodjournal.hematologylibrary.org/content/95/6/2031.long
Article (author)
File in questo prodotto:
File Dimensione Formato  
Blood 2000.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 286.16 kB
Formato Adobe PDF
286.16 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/175954
Citazioni
  • ???jsp.display-item.citation.pmc??? 15
  • Scopus 95
  • ???jsp.display-item.citation.isi??? ND
social impact